文献速递心外重症与机械循环支持肺外科先天性心脏病外科

ECMO作为胸科多器官移植桥接手段的应用

Extracorporeal membrane oxygenation as a bridge to thoracic multiorgan transplantation.
PubMed 文献 · J Heart Lung Transplant · 2024-09-27

基于UNOS数据库1987至2022年成人胸科多器官移植数据,共3927例中203例(5.2%)使用ECMO桥接。ECMO桥接者较未桥接者未校正生存率降低(p<0.001),但移植后存活超过30天者长期生存相似(p=0.82)。结论认为ECMO桥接与30天死亡率增加和长期生存降低相关。

要点

  • 胸科多器官移植中5.2%使用ECMO桥接,最常见为心肺移植(45.8%)。
  • ECMO桥接者未校正生存较未桥接者降低(p<0.001)。
  • 移植后存活超过30天者,ECMO与非ECMO长期生存相似(p=0.82)。

核心结论

  • ECMO作为胸科多器官移植桥接手段应用增加,与30天死亡率增加和长期生存降低相关。
  • 移植后存活超过30天的选择性患者中,ECMO桥接与非桥接者长期生存相似。

研究设计与样本

  • 使用UNOS数据库识别1987至2022年间接受胸科多器官移植的成人患者。
  • 排除标准为受者年龄<18岁及使用其他非ECMO机械循环支持桥接。
  • 共纳入3927例胸科多器官移植患者,其中203例(5.2%)接受ECMO桥接。

主要发现

  • ECMO桥接者中最常见为心肺移植(45.8%),其中心肾移植占34.5%,肺肾移植占11.8%。
  • 中位随访35.5个月,ECMO桥接者未校正生存较未桥接多器官移植受者降低(p<0.001)。
  • 移植后存活超过30天的患者中,ECMO与非ECMO者条件长期生存相似(p=0.82)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) has emerged as a crucial tool in the care of patients with multiorgan failure and is increasingly utilized as a bridge to transplantation. While data on ECMO as a bridge to isolated heart and lung transplantation have been described, our emerging experience with ECMO as a bridge to thoracic multiorgan transplantation is not yet well understood. METHODS: The United Network for Organ Sharing database was used to identify adult patients undergoing thoracic multiorgan transplantation between 1987 and 2022. Exclusion criteria were recipient age <18 and bridging with other non-ECMO mechanical circulatory support, Survival analysis was performed to compare outcomes between patients bridged to transplantation with ECMO and those who were not bridged. RESULTS: Of 3,927 patients undergoing thoracic multiorgan transplantation, a total of 203 (5.2%) patients received ECMO as a bridge to transplantation. Among ECMO recipients, patients were most commonly bridged to heart-lung (45.8%), followed by heart-kidney (34.5%), and lung-kidney transplantation (11.8%). At a median follow-up of 35.5 months, unadjusted survival among patients bridged with ECMO was decreased versus multiorgan transplant recipients who were not bridged (p < 0.001). Among patients surviving past 30 days following transplantation, conditional long-term survival was similar between ECMO and non-ECMO patients (p = 0.82). CONCLUSIONS: ECMO is increasingly utilized as a bridge to thoracic multiorgan transplantation and is associated with increased 30 day mortality and decreased long-term survival. In select patients surviving to 30 days following transplantation, similar long-term survival is seen between patients bridged with ECMO and those not bridged.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Heng EE, Krishnan A, Elde S, et al. Extracorporeal membrane oxygenation as a bridge to thoracic multiorgan transplantation. J Heart Lung Transplant. 2024. PMID: 39343333. doi:10.1016/j.healun.2024.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。